Surging stocks & race cups 🏆

Investor insights from Caulfield, Melbourne Racing Club

Welcome to The Stock Scoop, a community with fresh takes on the latest stock news, exclusive CEO interviews, and expert insights that matter most to investors like you.

I've never been crazy for horse races, but there's something about performance and competition that is undeniably engaging. Over the last fortnight, I interviewed CEOs from four ASX-listed companies presenting at Stocks On Track at The Melbourne Racing Club Caulfield.

Fascinators came together with finance for a day of presentations, insights and tips - for success. Just like a racehorse needs precision and strategy to win, the featured companies illustrated stories of grit, innovation and riding the waves of market conditions amid fierce competition.

Melbourne's weather blessed us with sunshine amid investor presentations. Much like winning on the track, investing requires consistency, preparation and the ability to seize opportunities when they arise.

Click the picture to see what I saw on and off the track at Caulfield

This issue of The Stock Scoop shares my key learnings from the event: 

PolyNovo (ASX:PNV):

Shares in PolyNovo are up more than 100% over the last year on the back of development and commercialisation of the company's innovative medical devices using its patented NovoSorb technology.

Owned exclusively by PolyNovo, NovoSorb can be used to manufacture a range of novel medical devices.

Speaking prior to the Stocks On Track event, PolyNovo Non-Executive Chair David Williams explains why the market has embraced PolyNovo’s flagship product, the company’s key growth drivers, and some of the strategic partnerships it has been pursuing.

Optiscan Imaging (ASX:OIL):

In another recent success story, shares in Optiscan Imaging have surged more than 170% over the last year as the commercial-stage medical technology company advances its suite of digital pathology and precision surgery hardware and software solutions.

Joining me ahead of the Stocks On Track event was Optiscan CEO and Managing Director Dr Camile Farah, who spoke about some of the company's recent milestones and plans for the year ahead.

“We're focused on moving our hardware and software through the clinical data collection phase and advancing our regulatory submissions and approvals,” he said. “And of course, we will continue to then focus on increasing revenue from our life sciences products and expanding into the vet medicine space.”

Magnetic Resources (ASX:MAU):

Gold explorer Magnetic Resources owns the Lady Julie Gold project, located in the heart of WA's Laverton Gold Belt, which is well known for producing quality long-life mines.

A drilling programme is currently underway at Lady Julie both to increase resources and upgrade resource categories.

I sat down with Magnetic’s Founder and Managing Director George Sakalidis ahead of Stocks On Track to hear more about Lady Julie and the company’s timeline for the completion of key development milestones there.

Praemium (ASX:PPS):

Praemium has created a platform of administration, investment and retirement-related services meeting the personalisation and customisation standards demanded by high-net-worth clients.

Its offering includes full-suite reporting and administration services as well as access to more complex investment categories such as property, art and private equity.

I spoke with Praemium Managing Director Anthony Wamsteker prior to the Stocks On Track event about the company’s strong organic growth, FY24 results, and recent new product release.

Disclaimer

The material contained in this email is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice.

We give no warranty to the accuracy, reliability or completeness of information that is contained in this email and exclude liability for any loss.

This email may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever.

We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this email.

Please see our full content disclaimer.